Skip to main content

Medical Applications for Biomaterials in Bolivia

  • Book
  • © 2015

Overview

  • Covers potential medical benefits of biomaterials in Bolivia
  • Details Bolivia as a model for the rest of South America in the use of biomaterials for public health
  • Examines Bolivia because of the extreme poverty and economic inequality
  • Contains a chapter devotes to quinoa
  • Includes an appendix on medicinal herbs
  • Includes supplementary material: sn.pub/extras

Part of the book series: SpringerBriefs in Public Health (BRIEFSPUBLIC)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (8 chapters)

Keywords

About this book

This book investigates the potential medical benefits natural biomaterials can offer in developing countries by analyzing the case of Bolivia. The book explores the medical and health related applications of Bolivian commodities: quinoa, barley, sugarcane, corn, sorghum and sunflower seeds. This book helps readers better understand some of the key health concerns facing countries like Bolivia and how naturally derived biomaterials and therapeutics could help substantially alleviate many of their problems.

Authors and Affiliations

  • School of Engineering & Applied Sciences, Harvard University, Cambridge, USA

    Susan Arias

  • School of Engineering & Applied Science, Harvard University, Cambridge, USA

    Sujata K. Bhatia

About the authors

Susan Arias graduated from Harvard University in May 2014 with a Bachelor of Arts Biomedical Engineering degree. She is currently working for a medtech focused venture fund.

Bibliographic Information

Publish with us